Professor Tufan Tükek, the Dean of Faculty of Istanbul University of Medicine, warned on saturday this masks should be worn indoors “at least until April or May” car restrictions related to the COVID-19 pandemic are relaxed in Turkey.
On Wednesday, Health Minister Fahrettin Koca revealed that Turkey was scrapping the outdoor mask requirement as the COVID-19 pandemic subsided thanks to the country’s vaccination efforts.
“We are talking about a pandemic that has started to diminish in intensity,” Tükek said.
Emphasizing this mask-wearing should be respected, Tükek said that after May, the pandemic will ease further in Turkey.
“Maybe the PCR tests won’t be done anymore and we will switch back to our normal life,” he said, also warning that hygiene precautions and mask-wearing should be a priority until the pandemic is totally over.
Tukek also says 80% of Turkey total population has antibodies against fight off COVID-19, including individuals who caught the virus and recovered, plus the ever-increasing number of vaccinated citizens.
the professor also stressed that education is a top priority for Turkey and should continue now that the number of cases have stabilized.
“The number of cases is going down,” he said.
“This trend will continue. I believe that people should always wear masks with them and use intermittently,” Tükek added, pointing out that whenever inside and near someone in a top-risk groupmasks should be properly worn.
Praising the health infrastructure of Turkey, Tükek also says that results Turkovac domestic vaccine also offer hope.
Temp worker results of a study comparing Turkey’s own COVID-19 vaccine, Turkovac with CoronaVac, which was developed by the Chinese Sinovac, were made public in January. the results show the local jab is 49.29% more succeeded in prevention of infections among vaccinees than CoronaVac. Both are inactive vaccines, and CoronaVac was the first to offer to the Turks public when the vaccination program has begun in January 2021.
Hacettepe University in the capital Ankara was conducting a study comparing the effectiveness and safety of two doses of Turkovac with two doses of CoronaVac. Professor Serhat Ünal, member of the Scientific Advisory Council on Coronavirus of the Ministry of Health and the coordinator national for Trials of phase 3 of Turkovac, joined professor Durusu Tanrıöver Mine, a scientist in load of the study and board member of Hacettepe University Vaccination Institute, in announcing the results at a press conference in Ankara. The study started on June 22 and the results cover analysis of results up until December 27, 2021.
Tanrıöver said the study included different phases, including an evaluation of the effectiveness of vaccines verified by polymerase chain reaction (PCR) tests performed with 1,182 volunteers of all ages of 18 and 55, with no history of COVID-19 and previous vaccinations. Some 73% of volunteers were male and 43% of all volunteers were people between the ages of 40 and 55 years old, while 38% were between the ages of 30 and 39 years old and the others were younger people.
Half of volunteers received two doses of CoronaVac and others half received two doses of Turkovac, with a length of 28 days between the two doses. Temp worker results indicated that the coronavirus infection rate among people vaccinated with CoronaVac was 8.96%, when it was 4.55% for those who had received Turkovac.
Turkovac could put an end to the apparent lethargy to get vaccinated among Turks public and reduce hesitation about the other two vaccines available. New Expeditions of the blow of the coronavirus developed by Turkish scientists were delivered all over Turkey last months, expanding the scope of the new vaccine that has been available in supply limited to city hospitals in past weeks.
Authorities expect Turkovac to be just the shot in arm vaccination late program Needs. Although largely successful, the lack of a third or boosters are administered, necessary car vaccines lose their effectiveness over time, menace to put the program in danger. East Turkovac available both as first dose for unvaccinated and booster for the vaccinated with other shots, including CoronaVac, an inactive vaccine like Turkovac and the first to be offered against COVID-19[feminineinTurkey[feminineinDinde
Turkey has launched studies to develop son first vaccine against combat the pandemic back in 2020 and under the coordination of the Ministry of Health and scientific bodies, with race researchers against time to develop injections and drugs. Turkovac, who wrapped up son final trials last year and received urgently use approval in December was the first local vaccine against COVID-19[FEMININEdevelopedbya[FEMININEdevelopedparunteam at the University of Erciyes. Last month, human trials were also spear for an adenoviral vaccine, which can be administered orally or nasally.
Mass vaccination helped cushion the impact of omicron, one fast-sprawl variant responsible for the majority of cases, including those of President Recep Tayyip Erdoğan and first Lady Emine Erdoğan who suffer from mild infections. The country broke up new recordings in daily cases in the past weeks to cause of omicron but hospitalizations remained low according to the Ministry of Health.
Describing the new measures during a press conference, Koca recently said that masks will no longer be mandatory indoors “if there is adequate ventilation” but added that they are still crucial in certain environments, such as around immunocompromised people people or these with diseases that can make a COVID-19 infection fatal.
Sites will no longer require people to scan son HES QR code on entry, Koca said, referring to Hayat Eve Sığar (Life Fits Into Home) app developed by the Ministry of Health which creates a QR code based on personal health records. “COVID-19 testing will not be required for those who show no symptoms,” he said. added.
koca also says that only 8% of people who tested positive for COVID-19 and died last month had no other illnesses, adding that “the remaining 92% were diagnosed with other diseases sooner.”
The Ministry of Health also published figures related to weekly incidence of COVID-19[feminineinThe81provincesofTurkey[feminineinLes81provincesdelaTurquiefor the week between February 12 and February 18. Numbers show a parent decline in cases per 100,000 people. Istanbul, the most populous cityreported just 617 cases per 100,000 when that number was around 1,216 for the capital Ankara and about 776 for the third plus grand city Izmir.
Istanbul had 717 cases in the first week of February, while Ankara and Izmir had 1,323 and 1,017 cases respectively.
Turkey was challenged by the omicron variant, which contributed to a strong rise in the number of daily cases since January. After breaking daily records last months, the country seems to be sinking into a new phase in the pandemic, with a decline in daily cases. On Sunday, daily cases fell to around 69,000, a far cry from more over 111,000 in at the beginning of February. A decline in cases were expected due to increased vaccination rate and increasing mass immunity. Experts predict the number of cases will rise further decrease later this month. Earlier high numbers attributed to mid-term review holiday Pause for schools that have seen higher mobility between and within cities.
Professor Tufan Tükek, the Dean of Faculty of Istanbul University of Medicine, warned on saturday this masks should be worn indoors “at least until April or May” car restrictions related to the COVID-19 pandemic are relaxed in Turkey.
On Wednesday, Health Minister Fahrettin Koca revealed that Turkey was scrapping the outdoor mask requirement as the COVID-19 pandemic subsided thanks to the country’s vaccination efforts.
“We are talking about a pandemic that has started to diminish in intensity,” Tükek said.
Emphasizing this mask-wearing should be respected, Tükek said that after May, the pandemic will ease further in Turkey.
“Maybe the PCR tests won’t be done anymore and we will switch back to our normal life,” he said, also warning that hygiene precautions and mask-wearing should be a priority until the pandemic is totally over.
Tukek also says 80% of Turkey total population has antibodies against fight off COVID-19, including individuals who caught the virus and recovered, plus the ever-increasing number of vaccinated citizens.
the professor also stressed that education is a top priority for Turkey and should continue now that the number of cases have stabilized.
“The number of cases is going down,” he said.
“This trend will continue. I believe that people should always wear masks with them and use intermittently,” Tükek added, pointing out that whenever inside and near someone in a top-risk groupmasks should be properly worn.
Praising the health infrastructure of Turkey, Tükek also says that results Turkovac domestic vaccine also offer hope.
Temp worker results of a study comparing Turkey’s own COVID-19 vaccine, Turkovac with CoronaVac, which was developed by the Chinese Sinovac, were made public in January. the results show the local jab is 49.29% more succeeded in prevention of infections among vaccinees than CoronaVac. Both are inactive vaccines, and CoronaVac was the first to offer to the Turks public when the vaccination program has begun in January 2021.
Hacettepe University in the capital Ankara was conducting a study comparing the effectiveness and safety of two doses of Turkovac with two doses of CoronaVac. Professor Serhat Ünal, member of the Scientific Advisory Council on Coronavirus of the Ministry of Health and the coordinator national for Trials of phase 3 of Turkovac, joined professor Durusu Tanrıöver Mine, a scientist in load of the study and board member of Hacettepe University Vaccination Institute, in announcing the results at a press conference in Ankara. The study started on June 22 and the results cover analysis of results up until December 27, 2021.
Tanrıöver said the study included different phases, including an evaluation of the effectiveness of vaccines verified by polymerase chain reaction (PCR) tests performed with 1,182 volunteers of all ages of 18 and 55, with no history of COVID-19 and previous vaccinations. Some 73% of volunteers were male and 43% of all volunteers were people between the ages of 40 and 55 years old, while 38% were between the ages of 30 and 39 years old and the others were younger people.
Half of volunteers received two doses of CoronaVac and others half received two doses of Turkovac, with a length of 28 days between the two doses. Temp worker results indicated that the coronavirus infection rate among people vaccinated with CoronaVac was 8.96%, when it was 4.55% for those who had received Turkovac.
Turkovac could put an end to the apparent lethargy to get vaccinated among Turks public and reduce hesitation about the other two vaccines available. New Expeditions of the blow of the coronavirus developed by Turkish scientists were delivered all over Turkey last months, expanding the scope of the new vaccine that has been available in supply limited to city hospitals in past weeks.
Authorities expect Turkovac to be just the shot in arm vaccination late program Needs. Although largely successful, the lack of a third or boosters are administered, necessary car vaccines lose their effectiveness over time, menace to put the program in danger. East Turkovac available both as first dose for unvaccinated and booster for the vaccinated with other shots, including CoronaVac, an inactive vaccine like Turkovac and the first to be offered against COVID-19[feminineinTurkey[feminineinDinde
Turkey has launched studies to develop son first vaccine against combat the pandemic back in 2020 and under the coordination of the Ministry of Health and scientific bodies, with race researchers against time to develop injections and drugs. Turkovac, who wrapped up son final trials last year and received urgently use approval in December was the first local vaccine against COVID-19[FEMININEdevelopedbya[FEMININEdevelopedparunteam at the University of Erciyes. Last month, human trials were also spear for an adenoviral vaccine, which can be administered orally or nasally.
Mass vaccination helped cushion the impact of omicron, one fast-sprawl variant responsible for the majority of cases, including those of President Recep Tayyip Erdoğan and first Lady Emine Erdoğan who suffer from mild infections. The country broke up new recordings in daily cases in the past weeks to cause of omicron but hospitalizations remained low according to the Ministry of Health.
Describing the new measures during a press conference, Koca recently said that masks will no longer be mandatory indoors “if there is adequate ventilation” but added that they are still crucial in certain environments, such as around immunocompromised people people or these with diseases that can make a COVID-19 infection fatal.
Sites will no longer require people to scan son HES QR code on entry, Koca said, referring to Hayat Eve Sığar (Life Fits Into Home) app developed by the Ministry of Health which creates a QR code based on personal health records. “COVID-19 testing will not be required for those who show no symptoms,” he said. added.
koca also says that only 8% of people who tested positive for COVID-19 and died last month had no other illnesses, adding that “the remaining 92% were diagnosed with other diseases sooner.”
The Ministry of Health also published figures related to weekly incidence of COVID-19[feminineinThe81provincesofTurkey[feminineinLes81provincesdelaTurquiefor the week between February 12 and February 18. Numbers show a parent decline in cases per 100,000 people. Istanbul, the most populous cityreported just 617 cases per 100,000 when that number was around 1,216 for the capital Ankara and about 776 for the third plus grand city Izmir.
Istanbul had 717 cases in the first week of February, while Ankara and Izmir had 1,323 and 1,017 cases respectively.
Turkey was challenged by the omicron variant, which contributed to a strong rise in the number of daily cases since January. After breaking daily records last months, the country seems to be sinking into a new phase in the pandemic, with a decline in daily cases. On Sunday, daily cases fell to around 69,000, a far cry from more over 111,000 in at the beginning of February. A decline in cases were expected due to increased vaccination rate and increasing mass immunity. Experts predict the number of cases will rise further decrease later this month. Earlier high numbers attributed to mid-term review holiday Pause for schools that have seen higher mobility between and within cities.